Skip to main content
Log in

AAPS PharmSciTech

An Official Journal of the American Association of Pharmaceutical Scientists

Publishing model:

Overview

AAPS PharmSciTech is an official journal of the American Association of Pharmaceutical Scientists, focusing on the research, development, and evaluation of pharmaceutical dosage forms and delivery systems.

  • Innovative in its content and practices, AAPS PharmSciTech uses technologically-driven tools and methods by which the scientific community can more efficiently disseminate their research.
  • Administers fast peer review with an average first decision time of 30 days.
  • Distinguished teams of international Editors and Editorial Advisory Board.
  • International readership with nearly 500,000 downloads per year.
  • Uses the continuous publishing model, allowing immediate citation upon publication.
  • Offers free color publication and supplemental files, including video.

Main Editor
  • Robert O. Williams
Journal Impact Factor
3.4 (2023)
5-year Journal Impact Factor
3.5 (2023)
Downloads
914,757 (2023)

Latest articles

Journal updates

  • The AAPS Journals Make Use of Portable Peer Review

    If your manuscript has been declined, and you are planning to submit your article to another of the four AAPS journals (AAPS Open, The AAPS Journal, AAPSPharmSciTech, or Pharmaceutical Research), we can help make the peer review process faster and smoother by extending the use of previous peer reviewer comments! Portable Peer Review, an opt-into service available for any author of these journals, allows us to share, between the portfolio, previous peer review comments and reviewer names, subject to approval of all parties. This can help speed up the assessment process, should the editor choose to make a decision on the basis of the comments and revision. Interested?  Email us with the name of the journal to which you are going to submit. Note: Portable peer review is opt-in only, available at the authors’ preference, and the reviewer identities and comments will only be shared between offices, not to the author.

  • AAPS PharmSciTech High Impact Article Award

    AAPS PharmSciTech High Impact Article Award Recognizing an article published in the last two years in AAPS PharmSciTech that is judged exceptional by the editors for its impact on pharmaceutical technology.

    Awardee/Corresponding Author: Peter Mack, Ph.D., Astrazeneca Co-Authors: Amber Doty, Jon Schroeder, Kou Vang, Mark Sommerville, Ph.D., Mervin Taylor, Brad Flynn, and David Lechuga-Ballesteros, Ph.D.

    Watch the video here.


  • Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger

    AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.

Journal information

Electronic ISSN
1530-9932
Co-Publisher information
American Association of Pharmaceutical Scientists
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. Baidu
  4. CLOCKSS
  5. CNKI
  6. CNPIEC
  7. Chemical Abstracts Service (CAS)
  8. Dimensions
  9. EBSCO
  10. EMBASE
  11. Google Scholar
  12. INIS Atomindex
  13. Japanese Science and Technology Agency (JST)
  14. Medline
  15. Meta
  16. Naver
  17. Norwegian Register for Scientific Journals and Series
  18. OCLC WorldCat Discovery Service
  19. Portico
  20. ProQuest
  21. Reaxys
  22. SCImago
  23. SCOPUS
  24. Science Citation Index Expanded (SCIE)
  25. TD Net Discovery Service
  26. UGC-CARE List (India)
  27. Wanfang
Copyright information

Rights and permissions

Editorial policies

© American Association of Pharmaceutical Scientists

Navigation